CT
CTTQ Pharma
Lianyungang CNFounded 20036,000 employees
Private CappharmaPrivateOncologyGI
Platform: Hepatitis GI
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CTT-403 | CTT-403 | Phase 1 | 1 | JAK2 | Endometrial CaHemophilia A | ||
| Riluderotide | CTT-1024 | Phase 2/3 | 1 | Menin | Atopic DermObesity | ||
| Tiratapinarof | CTT-1296 | Phase 3 | 3 | TYK2 | PTSDDravet |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)